Papers By The 25% M.E Group Patrons, Trustees & Advisers
PURPOSE This document presents a simplified and clinically practical definition of Myalgic Encephalomyelitis (M.E.) and Chronic Fatigue Syndrome (CFS). It aims to improve understanding of these conditions by focusing on measurable, testable criteria and by highlighting the multi‑system nature of the illness. KEY POINTS 1. Multi‑System Illness M.E. is not a single isolated disease but…
Purpose This page explains why Myalgic Encephalomyelitis (M.E.) is often described as a “poorly understood” disease in research and clinical settings. It explores the historical, scientific, and systemic reasons behind this label and clarifies the current state of biomedical knowledge. Key Points 1. The “Poorly Understood” Label M.E. is frequently described as a poorly understood…
Purpose This page explains how bone loss (osteopenia and osteoporosis) can develop in people with Myalgic Encephalomyelitis (M.E.), the contributing factors involved, and how bone health can be assessed and managed while respecting the limitations of the illness. Key Points 1. Overview of Bone Loss in M.E. Bone loss can occur over time in people…
Purpose This page explains neuroimmune dysfunction in Myalgic Encephalomyelitis (M.E.), focusing on how abnormalities in the brain, immune system, autonomic nervous system, and circulation interact to produce the characteristic symptoms of the disease. Key Points 1. Neuroimmune Dysfunction Overview M.E. involves a disruption between the nervous system and immune system The body becomes stuck in…
Purpose This page explains Post-Exertional Neuroimmune Exhaustion (PENE), the defining feature of Myalgic Encephalomyelitis (M.E.) according to the International Consensus Criteria. It outlines what PENE is, how it presents, and why it is central to understanding and diagnosing the disease. Key Points 1. Definition of PENE PENE is the core and defining feature of M.E.%20%20in%20ME.pdf)…
Purpose This page summarises findings from research reviewing urinary biomarkers in Myalgic Encephalomyelitis (M.E./ME/CFS). It explains whether urine-based testing can identify consistent biological patterns and support diagnosis, while outlining current limitations. Key Points 1. Overall Findings There is no single validated urinary biomarker for M.E. However, research shows repeated patterns of metabolic disruption Findings suggest…
Purpose This page explains how people with Myalgic Encephalomyelitis (M.E.) can identify and manage their personal activity baseline. It outlines the importance of pacing, understanding individual limits, and preventing symptom worsening caused by overexertion. Key Points 1. What is an Activity Baseline An activity baseline is the level of physical, cognitive, and sensory activity a…
Purpose This page provides an expanded overview of Myalgic Encephalomyelitis (M.E.) based on detailed clinical descriptions. It explains the core nature of the disease, its defining features, and the wide range of neurological, autonomic, immune, and systemic symptoms affecting multiple body systems. Key Points 1. Overview of M.E. M.E. is a distinct neurological disease recognised…
Purpose This page provides a structured overview of the wide range of symptoms associated with Myalgic Encephalomyelitis (M.E.) as defined by the International Consensus Criteria. It aims to help patients, carers, and professionals understand the complexity of the illness and its multi-system impact. Key Points 1. Understanding M.E. M.E. is a serious multi-system neurological disease…
Purpose This page explains the relationship between Fibromyalgia (FM) and Myalgic Encephalomyelitis (M.E.), highlighting where the conditions overlap, how they differ, and why they are often confused or diagnosed together. Key Points 1. Overview of Each Condition Fibromyalgia (FM): Primarily a pain-focused condition Characterised by widespread musculoskeletal pain and sensitivity Myalgic Encephalomyelitis (M.E.): A multi-system…